Selmeczi Katalin, Robert Anne, Claparols Catherine, Meunier Bernard
Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, 31077 Cedex 4, Toulouse, France.
FEBS Lett. 2004 Jan 2;556(1-3):245-8. doi: 10.1016/s0014-5793(03)01448-0.
In vitro, the heme cofactor of human iron(II) hemoglobin was efficiently and quickly alkylated at meso positions by the peroxide-based antimalarial drug artemisinin, leading to heme-artemisinin-derived covalent adducts. This reaction occurred in the absence of any added protease or in the presence of an excess of an extra non-heme protein, or even when artemisinin was added to hemolysed human blood. This activation of artemisinin by the heme moiety of non-digested hemoglobin clearly indicates the high affinity of this drug for heme, and its efficient alkylating ability under very mild conditions.
在体外,基于过氧化物的抗疟药物青蒿素能在中卟啉位置高效快速地烷基化人亚铁血红蛋白的血红素辅因子,生成血红素-青蒿素衍生的共价加合物。该反应在未添加任何蛋白酶的情况下、存在过量额外非血红素蛋白时均可发生,甚至将青蒿素添加到溶血的人血中时也会发生。未消化血红蛋白的血红素部分对青蒿素的这种激活作用清楚地表明该药物对血红素具有高亲和力,且在非常温和的条件下具有高效的烷基化能力。